Literature DB >> 23376058

Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP.

Weiguo Yao1, Yanlu Zhang, Rukhsana Jabeen, Evelyn T Nguyen, David S Wilkes, Robert S Tepper, Mark H Kaplan, Baohua Zhou.   

Abstract

Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine important for the initiation and development of T helper (Th2) cell-mediated allergic inflammation. In this study, we identified a positive association between interleukin-9 (IL-9) and TSLP concentration in the serum of infants with atopic dermatitis. In primary cell cultures, the addition of TSLP led to an increase in IL-9 production from human and mouse Th9 cells, and induced an increase in signal transducer and activator of transcription 5 (STAT5) activation and binding to the Il9 promoter. In vivo, use of an adoptive transfer model demonstrated that TSLP promoted IL-9-dependent, Th9 cell-induced allergic inflammation by acting directly on T cells. Moreover, transgenic expression of TSLP in the lung stimulated IL-9 production in vivo, and anti-IL-9 treatment attenuated TSLP-induced airway inflammation. Together, our results demonstrate that TSLP promotes Th9 cell differentiation and function and define a requirement for IL-9 in TSLP-induced allergic inflammation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376058      PMCID: PMC3582776          DOI: 10.1016/j.immuni.2013.01.007

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  53 in total

Review 1.  Functions of thymic stromal lymphopoietin in immunity and disease.

Authors:  Yanlu Zhang; Baohua Zhou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells.

Authors:  Yui-Hsi Wang; Tomoki Ito; Yi-Hong Wang; Bernhard Homey; Norihiko Watanabe; Rachel Martin; Christopher J Barnes; Bradley W McIntyre; Michel Gilliet; Rakesh Kumar; Zhengbin Yao; Yong-Jun Liu
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

3.  Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin.

Authors:  Miyuki Omori; Steven Ziegler
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

4.  TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells.

Authors:  Danielle Fontenot; Hong He; Shino Hanabuchi; Pramod N Nehete; Minying Zhang; Mikyoung Chang; Bharti Nehete; Yui-Hsi Wang; Yi-Hong Wang; Zhong-Min Ma; Hai-Chon Lee; Steven F Ziegler; Amy N Courtney; Christopher J Miller; Shao-Cong Sun; Yong-Jun Liu; K Jagannadha Sastry
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-21       Impact factor: 11.205

5.  TSLP conditions the lung immune environment for the generation of pathogenic innate and antigen-specific adaptive immune responses.

Authors:  Mark B Headley; Baohua Zhou; Weihui X Shih; Theingi Aye; Michael R Comeau; Steven F Ziegler
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

6.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

7.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Toshiyuki Hori; Guy J Delespesse; Norihiko Watanabe; F Xiao-Feng Qin; Zhengbin Yao; Wei Cao; Yong-Jun Liu
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

8.  A role for TSLP in the development of inflammation in an asthma model.

Authors:  Amin Al-Shami; Rosanne Spolski; John Kelly; Andrea Keane-Myers; Warren J Leonard
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

9.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

10.  Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness.

Authors:  U A Temann; G P Geba; J A Rankin; R A Flavell
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more
  79 in total

1.  Thymic stromal lymphopoietin-mediated epicutaneous inflammation promotes acute diarrhea and anaphylaxis.

Authors:  Hongwei Han; Tennille D Thelen; Michael R Comeau; Steven F Ziegler
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Thymic stromal lymphopoietin-induced interleukin-17A is involved in the development of IgE-mediated atopic dermatitis-like skin lesions in mice.

Authors:  Nobuaki Mizutani; Chutha Sae-Wong; Sureeporn Kangsanant; Takeshi Nabe; Shin Yoshino
Journal:  Immunology       Date:  2015-09-24       Impact factor: 7.397

3.  Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.

Authors:  Ji Yang; Qiao Li; Xue Yang; Ming Li
Journal:  Mol Med       Date:  2015-04-15       Impact factor: 6.354

Review 4.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

5.  Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9+ and IL-13+ type 2 innate lymphoid cell subpopulations.

Authors:  Mukesh Verma; Sucai Liu; Lidia Michalec; Anand Sripada; Magdalena M Gorska; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2017-11-10       Impact factor: 10.793

Review 6.  TGFβ in T cell biology and tumor immunity: Angel or devil?

Authors:  Eric Tu; Pei Zhi Cheryl Chia; Wanjun Chen
Journal:  Cytokine Growth Factor Rev       Date:  2014-07-29       Impact factor: 7.638

7.  Th9 cell development requires a BATF-regulated transcriptional network.

Authors:  Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression.

Authors:  Wei Liao; Rosanne Spolski; Peng Li; Ning Du; Erin E West; Min Ren; Suman Mitra; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

9.  Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells.

Authors:  Il-Kyu Kim; Byung-Seok Kim; Choong-Hyun Koh; Jae-Won Seok; Jun-Seok Park; Kwang-Soo Shin; Eun-Ah Bae; Ga-Eun Lee; Hyewon Jeon; Jaebeom Cho; Yujin Jung; Daehee Han; Byoung S Kwon; Ho-Young Lee; Yeonseok Chung; Chang-Yuil Kang
Journal:  Nat Med       Date:  2015-08-17       Impact factor: 53.440

10.  STAT3 Impairs STAT5 Activation in the Development of IL-9-Secreting T Cells.

Authors:  Matthew R Olson; Felipe Fortino Verdan; Matthew M Hufford; Alexander L Dent; Mark H Kaplan
Journal:  J Immunol       Date:  2016-03-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.